Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 1.016
Filter
1.
J Appl Microbiol ; 135(6)2024 Jun 03.
Article in English | MEDLINE | ID: mdl-38802124

ABSTRACT

AIMS: Anthracnose caused by Colletotrichum species is one of the most devastating diseases of fruits and crops. We isolated and identified an antifungal compound from the mushroom Coprinus comatus and investigated its inhibitory potential against anthracnose disease-causing fungi with the goal of discovering natural products that can suppress anthracnose-caused plant disease. METHODS AND RESULTS: The culture filtrate of C. comatus was subjected to a bioassay-guided isolation of antifungal compounds. The active compound was identified as orsellinaldehyde (2,4-dihydroxy-6-methylbenzaldehyde) based on mass spectroscopy and nuclear magnetic resonance analyses. Orsellinaldehyde displayed broad-spectrum inhibitory activity against different plant pathogenic fungi. Among the tested Colletotrichum species, it exhibited the lowest IC50 values on conidial germination and germ tube elongation of Colletotrichum orbiculare. The compound also showed remarkable inhibitory activity against Colletotrichum gloeosporiodes. The staining of Colletotrichum conidia with fluorescein diacetate and propidium iodide demonstrated that the compound is fungicidal. The postharvest in-vivo detached fruit assay indicated that orsellinaldehyde suppressed anthracnose lesion symptoms on mango and cucumber fruits caused by C. gloeosporioides and C. orbiculare, respectively. CONCLUSIONS: Orsellinaldehyde was identified as a potent antifungal compound from the culture filtrate of C. comatus. The inhibitory and fungicidal activities of orsellinaldehyde against different Colletotrichum species indicate its potential as a fungicide for protecting various fruits against anthracnose disease-causing fungi.


Subject(s)
Colletotrichum , Coprinus , Plant Diseases , Colletotrichum/drug effects , Plant Diseases/microbiology , Plant Diseases/prevention & control , Benzaldehydes/pharmacology , Antifungal Agents/pharmacology , Fungicides, Industrial/pharmacology , Spores, Fungal/drug effects
2.
Expert Rev Hematol ; 17(6): 255-260, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38753522

ABSTRACT

BACKGROUND: To date, there is limited evidence on patients utilizing both voxelotor and darbepoetin alfa and its impact on hemoglobin levels. The objective is to evaluate the effect of voxelotor and darbepoetin alfa on hemoglobin levels in patients with SCD. RESEARCH DESIGN AND METHODS: This was a retrospective chart review study that assessed the primary independent variable as the utilization of either voxelotor alone, darbepoetin alfa alone, or the concurrent administration of voxelotor and darbepoetin alfa. Descriptive statistics were utilized to obtain the mean standard deviation for numerical variables and proportions for categorical variables. RESULTS: A total of 23 participants were included in this study. When comparing baseline to 2 months and 3 months, participants on voxelotor alone experienced a 3% decrease and a 6.6% increase in hemoglobin, darbepoetin alfa alone group a 4.3% decrease and a 0.6% increase in hemoglobin and voxelotor and darbepoetin group a 4.4% decrease and a 0.5% decrease in hemoglobin levels. Fifty percent of the participants in the voxelotor group and 6 (66.7%) participants in the voxelotor plus darbepoetin alfa group experienced adverse drug events. CONCLUSIONS: Voxelotor resulted in a clinically significant difference in the percent change of hemoglobin from baseline to 3 months.


Subject(s)
Anemia, Sickle Cell , Darbepoetin alfa , Erythropoietin , Hemoglobins , Humans , Darbepoetin alfa/therapeutic use , Darbepoetin alfa/administration & dosage , Male , Erythropoietin/therapeutic use , Erythropoietin/analogs & derivatives , Female , Retrospective Studies , Anemia, Sickle Cell/complications , Anemia, Sickle Cell/drug therapy , Anemia, Sickle Cell/blood , Hemoglobins/analysis , Adult , Hematinics/therapeutic use , Middle Aged , Treatment Outcome , Adolescent , Young Adult , Benzaldehydes/therapeutic use , Benzaldehydes/administration & dosage , Benzaldehydes/pharmacology , Pyrazines , Pyrazoles
3.
Plant Physiol Biochem ; 211: 108672, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38718531

ABSTRACT

Luminescent materials can adjust the spectrum of light energy utilization by plants. However, current research on the effects of luminescent materials on aquatic plants and periphytic biofilms is limited. This study investigated the effects of the luminescent materials 4-(di-p-tolylamino) benzaldehyde-A (DTB-A) and 4-(di-p-tolylamino) benzaldehyde-M (DTB-M) on the submerged macrophyte Vallisneria natans (V. natans) and periphytic biofilm. Result demonstrated that low concentrations of DTB (0.1 µM) significantly promoted the growth and photosynthetic rate of V. natans. In terms of enzyme activity, exposure to a higher concentration of DTB (10 µM) increased the activities of peroxidase (POD), superoxide dismutase (SOD) and catalase (CAT). A combination of DTB-A and DTB-M treatment significantly changed the V. natans morphology and physiological characteristics, reducing the thickness of the cell wall and subsequently, promoting protein accumulation in leaves. There was no difference in the removal of ammonia or phosphate by V. natans at the 0.1 µM concentration, and the removal of ammonia and phosphate by V. natans decreased significantly as the concentration of luminescent material increased. A total of 3563 OTUs were identified in the biofilm community. The microbial community was dominated by Pseudomonas and Fusobacteria. Furthermore, results showed that an obvious decrease in diversity in the DTB-A and DTB-M mixed treatment group. In addition, the migratory aggregation of DTB molecules in plants was observed by fluorescence imaging. Overall, these findings extend our understanding of the mechanism of effect of luminescent materials on submerged macrophytes and their periphytic microorganisms.


Subject(s)
Biofilms , Hydrocharitaceae , Biofilms/drug effects , Biofilms/growth & development , Hydrocharitaceae/metabolism , Hydrocharitaceae/microbiology , Benzaldehydes/metabolism , Benzaldehydes/pharmacology , Photosynthesis/drug effects , Luminescence , Catalase/metabolism , Peroxidase/metabolism , Plant Leaves/metabolism , Superoxide Dismutase/metabolism , Luminescent Agents/metabolism
4.
Food Chem ; 453: 139612, 2024 Sep 30.
Article in English | MEDLINE | ID: mdl-38772306

ABSTRACT

Fusarium oxysporum and Botrytis cinerea are the main pathogens that cause fruit decay and reduce the postharvest shelf life of cherry tomatoes. Boosting the potency of natural products requires implementing structural modification to combat postharvest pathogens. Herein, we developed a novel Vanillin-Deep Eutectic Agent (V-DEA) from natural compounds and evaluated its effectiveness against tomato fruit rot pathogens. The results demonstrated that V-DEA suppressed mycelium growth and spore germination of F. oxysporum and B. cinerea by enhancing cell membrane permeability, increasing lipid peroxidation, and inhibiting enzyme activities. Importantly, using 8-mM V-DEA successfully prevented postharvest decay in cherry tomatoes, while 4-mM significantly extended their shelf life by reducing weight loss and shriveling, and enhancing key fruit qualities such as total soluble solids, ascorbic acid, tartaric acid, and lycopene. In conclusion, V-DEA exhibits dual properties as a potent pathogen inhibitor and antioxidant activity, thus prolonging the shelf life of cherry tomatoes.


Subject(s)
Benzaldehydes , Botrytis , Food Preservation , Fruit , Fusarium , Plant Diseases , Solanum lycopersicum , Solanum lycopersicum/microbiology , Solanum lycopersicum/chemistry , Solanum lycopersicum/growth & development , Benzaldehydes/pharmacology , Benzaldehydes/chemistry , Botrytis/growth & development , Botrytis/drug effects , Food Preservation/methods , Fruit/chemistry , Fruit/microbiology , Plant Diseases/microbiology , Plant Diseases/prevention & control , Fusarium/drug effects , Fusarium/growth & development , Fusarium/metabolism , Food Storage
5.
Biomed Pharmacother ; 175: 116692, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38701569

ABSTRACT

CCl4 toxicity is a fatal condition that can cause numerous organ dysfunctions. We evaluated and compared the protective effects of cuminaldehyde (CuA), thymoquinone (TQ), and gallic acid (GA) on CCl4-induced pulmonary and renal toxicity in rats. The impacts of these compounds on CCl4-induced oxidative stress, inflammation, and morphological alterations were examined. The results showed that the compounds under investigation prevented CCl4 from significantly increasing pulmonary and renal lipid peroxidation and NO levels, as well as massively depleting GSH levels and GPX and SOD activities. Moreover, they suppressed the CCl4-induced increase in mucus secretion in the lung and upregulated the gene expression of pulmonary and renal NF-Ò¡B, iNOS, TNF-α, and COX-2. The heatmap cluster plots showed that GA and TQ had better protective potencies than CuA. The external organ morphology, histopathological results, and chest X-ray analysis confirmed the toxicity of CCl4 and the protective influences of the tested compounds in both the lungs and kidneys of rats. These compounds displayed predicted competitive inhibitory effects on iNOS activity and may block the IL-13α2 receptor, as revealed by molecular docking analysis. Thus, CuA, TQ, and GA, particularly the latter two, are prospective protective compounds against the pulmonary and renal toxicity caused by CCl4.


Subject(s)
Benzaldehydes , Benzoquinones , Carbon Tetrachloride , Gallic Acid , Kidney , Lung , NF-kappa B , Oxidative Stress , Reactive Oxygen Species , Signal Transduction , Animals , Gallic Acid/pharmacology , Benzoquinones/pharmacology , Signal Transduction/drug effects , Male , NF-kappa B/metabolism , Reactive Oxygen Species/metabolism , Rats , Carbon Tetrachloride/toxicity , Kidney/drug effects , Kidney/pathology , Kidney/metabolism , Benzaldehydes/pharmacology , Lung/drug effects , Lung/pathology , Lung/metabolism , Oxidative Stress/drug effects , Molecular Docking Simulation , Cymenes/pharmacology , Protective Agents/pharmacology , Antioxidants/pharmacology , Lipid Peroxidation/drug effects , Rats, Wistar , Rats, Sprague-Dawley
6.
Plant J ; 119(1): 84-99, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38578218

ABSTRACT

Tuta absoluta ("leafminer"), is a major pest of tomato crops worldwide. Controlling this insect is difficult due to its efficient infestation, rapid proliferation, and resilience to changing weather conditions. Furthermore, chemical pesticides have only a short-term effect due to rapid development of T. absoluta strains. Here, we show that a variety of tomato cultivars, treated with external phenylalanine solutions exhibit high resistance to T. absoluta, under both greenhouse and open field conditions, at different locations. A large-scale metabolomic study revealed that tomato leaves absorb and metabolize externally given Phe efficiently, resulting in a change in their volatile profile, and repellence of T. absoluta moths. The change in the volatile profile is due to an increase in three phenylalanine-derived benzenoid phenylpropanoid volatiles (BPVs), benzaldehyde, phenylacetaldehyde, and 2-phenylethanol. This treatment had no effect on terpenes and green leaf volatiles, known to contribute to the fight against insects. Phe-treated plants also increased the resistance of neighboring non-treated plants. RNAseq analysis of the neighboring non-treated plants revealed an exclusive upregulation of genes, with enrichment of genes related to the plant immune response system. Exposure of tomato plants to either benzaldehyde, phenylacetaldehyde, or 2-phenylethanol, resulted in induction of genes related to the plant immune system that were also induced due to neighboring Phe-treated plants. We suggest a novel role of phenylalanine-derived BPVs as mediators of plant-insect interactions, acting as inducers of the plant defense mechanisms.


Subject(s)
Phenylalanine , Plant Leaves , Solanum lycopersicum , Volatile Organic Compounds , Solanum lycopersicum/genetics , Solanum lycopersicum/metabolism , Solanum lycopersicum/parasitology , Phenylalanine/metabolism , Volatile Organic Compounds/metabolism , Animals , Plant Leaves/metabolism , Plant Leaves/drug effects , Plant Leaves/parasitology , Benzaldehydes/metabolism , Benzaldehydes/pharmacology , Acetaldehyde/analogs & derivatives , Acetaldehyde/metabolism , Acetaldehyde/pharmacology , Moths/physiology , Moths/drug effects , Plant Diseases/parasitology , Plant Diseases/immunology , Manduca/physiology
7.
Mol Cells ; 47(5): 100066, 2024 May.
Article in English | MEDLINE | ID: mdl-38679413

ABSTRACT

Particulate matter 2.5 (PM2.5) poses a serious threat to human health and is responsible for respiratory disorders, cardiovascular diseases, and skin disorders. 3-Bromo-4,5-dihydroxybenzaldehyde (3-BDB), abundant in marine red algae, exhibits anti-inflammatory, antioxidant, and antidiabetic activities. In this study, we investigated the protective mechanisms of 3-BDB against PM2.5-induced cell cycle arrest and autophagy in human keratinocytes. Intracellular reactive oxygen species generation, DNA damage, cell cycle arrest, intracellular Ca2+ level, and autophagy activation were tested. 3-BDB was found to restore cell proliferation and viability which were reduced by PM2.5. Furthermore, 3-BDB reduced PM2.5-induced reactive oxygen species levels, DNA damage, and attenuated cell cycle arrest. Moreover, 3-BDB ameliorated the PM2.5-induced increases in cellular Ca2+ level and autophagy activation. While PM2.5 treatment reduced cell growth and viability, these were restored by the treatment with the autophagy inhibitor bafilomycin A1 or 3-BDB. The findings indicate that 3-BDB ameliorates skin cell death caused by PM2.5 via inhibiting cell cycle arrest and autophagy. Hence, 3-BDB can be exploited as a preventive/therapeutic agent for PM2.5-induced skin impairment.


Subject(s)
Autophagy , Benzaldehydes , Cell Cycle Checkpoints , Keratinocytes , Particulate Matter , Reactive Oxygen Species , Autophagy/drug effects , Humans , Keratinocytes/drug effects , Keratinocytes/metabolism , Particulate Matter/toxicity , Benzaldehydes/pharmacology , Cell Cycle Checkpoints/drug effects , Reactive Oxygen Species/metabolism , Cell Proliferation/drug effects , Calcium/metabolism , Cell Survival/drug effects , DNA Damage/drug effects
8.
Chem Biol Interact ; 394: 111003, 2024 May 01.
Article in English | MEDLINE | ID: mdl-38608998

ABSTRACT

The use of flavored e-liquids in electronic nicotine delivery systems (ENDS) has become very popular in recent years, but effects of these products have not been well characterized outside the lung. In this study, acute exposure to the popular flavoring vanillin (VAN) was performed on human proximal tubule (HK-2) kidney cells. Cells were exposed to 0-1000 µM VAN for 24 or 48 h and cellular stress responses were determined. Mitochondrial viability using MTT assay showed a significant decrease between the control and 1000 µM group by 48 h. Seahorse XFp analysis showed significantly increased basal respiration, ATP production, and proton leak after 24 h exposure. By 48 h exposure, these parameters remained significantly increased in addition to non-mitochondrial respiration and maximal respiration. Glycolytic activity after 24 h exposure showed significant decreases in glycolysis, glycolytic capacity, glycolytic reserve, and non-glycolytic acidification. The autophagy markers microtubule-associated protein 1A/1B light chain 3 (LC3B-I and LC3B-II) were probed via western blotting. The ratio of LC3B-II/LC3B-I was significantly increased after 24 h exposure to VAN, but by 48 h this ratio significantly decreased. The mitophagy marker PINK1 showed an increasing trend at 24 h, and its downstream target Parkin was significantly increased between the control and 750 µM group only. Finally, the oxidative stress marker 4-HNE was significantly decreased after 48 h exposure to VAN. These results indicate that acute exposure to VAN in the kidney HK-2 model can induce energy and autophagic changes within the cell.


Subject(s)
Autophagy , Benzaldehydes , Epithelial Cells , Flavoring Agents , Kidney Tubules, Proximal , Humans , Autophagy/drug effects , Kidney Tubules, Proximal/drug effects , Kidney Tubules, Proximal/cytology , Kidney Tubules, Proximal/metabolism , Flavoring Agents/pharmacology , Flavoring Agents/toxicity , Benzaldehydes/pharmacology , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Cell Line , Glycolysis/drug effects , Mitochondria/drug effects , Mitochondria/metabolism , Energy Metabolism/drug effects , Oxidative Stress/drug effects
9.
Arch Oral Biol ; 163: 105976, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38640776

ABSTRACT

OBJECTIVE: The present study investigated the effects of 4-hydroxy-3-methoxybenzaldehyde (4-H-3-MB) against Streptococcus mutans (S. mutans) using an in vitro cariogenic biofilm model. DESIGN: The antimicrobial susceptibility of biofilm-forming S. mutans was evaluated by disc diffusion method. In vitro investigations were performed using crystal violet staining assay (biofilm assay), exopolysaccharide (EPS) assay, acid production, growth curve analysis, optical microscopic, and FE-SEM analyses to determine the antibiofilm activity of 4-H-3-MB. RESULTS: S. mutans (SDC-05) was resistant to ampicillin, piperacillin/tazobactam and ceftriaxone, whereas the other strains of S. mutans (SDC-01, 02, 03 and SDC-04) were sensitive to all the antibiotics tested. 4-H-3-MB showed promising antibiofilm activity on S. mutans UA159 (79.81 %, 67.76 % and 56.31 %) and S. mutans SDC-05 (77.00 %, 59.48 % and 48.22 %) at the lowest concentration of 0.2, 0.1, 0.05 mg/ml. 4-H-3-MB did not inhibit bacterial growth even at concentrations 0.2 mg/ml. Similarly, 4-H-3-MB led to significant attrition in exopolysaccharide (EPS) and acid production by S. mutans UA159 and S. mutans (SDC-05) at the concentration of 0.2, 0.1 mg/ml, respectively. Optical microscopy and FE-SEM analysis 4-H-3-MB reduced the biofilm thickness of S. mutans UA159 and S. mutans SDC-05 relative to the untreated specimens. CONCLUSION: 4-H-3-MB significantly inhibited biofilm formation by S. mutans in a dose-dependent manner. Hence, our findings indicate that the active principle of 4-H-3-MB could be used as a biofilm inhibiting agent against S. mutans.


Subject(s)
Anti-Bacterial Agents , Benzaldehydes , Biofilms , Microbial Sensitivity Tests , Quorum Sensing , Streptococcus mutans , Virulence Factors , Streptococcus mutans/drug effects , Biofilms/drug effects , Quorum Sensing/drug effects , Benzaldehydes/pharmacology , Anti-Bacterial Agents/pharmacology , Polysaccharides, Bacterial/pharmacology , Microscopy, Electron, Scanning , In Vitro Techniques
10.
Eur J Pharm Sci ; 198: 106778, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38653341

ABSTRACT

Uric acid, the metabolic product of purines, relies on xanthine oxidase (XOD) for production. XOD is a target for the development of drugs for hyperuricemia (HUA) and gout. Currently, treatment options remain limited for gout patients. 3, 4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a derivative of the natural product protocatechualdehyde with good biological activity. In this work, we identify a DHNB thiosemicarbazide class of compounds that targets XOD. 3,4-Dihydroxy-5-nitrobenzaldehyde phenylthiosemicarbazone can effectively inhibit XOD activity (IC50 value: 0.0437 µM) and exhibits a mixed inhibitory effect. In a mouse model of acute hyperuricemia, a moderate dose (10 mg/kg.w) of 3,4-dihydroxy-5-nitrobenzaldehyde phenylthiosemicarbazide effectively controlled the serum uric acid content and significantly inhibited serum XOD activity. In addition, 3,4-Dihydroxy-5-nitrobenzaldehyde phenylthiosemicarbazide showed favorable safety profiles, and mice treated with the target compound did not show any symptoms of general toxicity following a single dose of 500 mg/kg. In the allopurinol group, 50 % of the mice died. These results provide a structural framework and mechanism of XOD inhibition that may facilitate the design of hyperuricemia and gout treatments.


Subject(s)
Benzaldehydes , Gout , Hyperuricemia , Semicarbazides , Xanthine Oxidase , Animals , Hyperuricemia/drug therapy , Male , Semicarbazides/pharmacology , Semicarbazides/therapeutic use , Semicarbazides/chemistry , Mice , Benzaldehydes/pharmacology , Benzaldehydes/therapeutic use , Benzaldehydes/chemistry , Gout/drug therapy , Xanthine Oxidase/antagonists & inhibitors , Xanthine Oxidase/metabolism , Uric Acid/blood , Humans
11.
Curr Microbiol ; 81(6): 156, 2024 Apr 24.
Article in English | MEDLINE | ID: mdl-38656548

ABSTRACT

Aspergillus fumigatus and Fusarium solani infections have become severe health threat; both pathogens are considered a priority due to the increasing emergence of antifungal-resistant strains and high mortality rates. Therefore, the discovery of new therapeutic strategies has become crucial. In this study, we evaluated the antifungal and antivirulence effects of vanillin and tannic acid against Aspergillus fumigatus and Fusarium solani. The minimum inhibitory concentrations of the compounds were determined by the microdilution method in RPMI broth in 96-well microplates according to CLSI. Conidial germination, protease production, biofilm formation, and in vivo therapeutic efficacy assays were performed. The results demonstrated that vanillin and tannic acid had antifungal activity against Aspergillus fumigatus, while tannic acid only exhibited antifungal activity against Fusarium solani. We found that vanillin and tannic acid inhibited conidial germination and secreted protease production and biofilm formation of the fungal pathogens using sub-inhibitory concentrations. Besides, vanillin and tannic acid altered the fungal membrane permeability, and both compounds showed therapeutic effect against aspergillosis and fusariosis in an infection model in Galleria mellonella larvae. Our results highlight the antivirulence effect of vanillin and tannic acid against priority pathogenic fungi as a possible therapeutic alternative for human fungal infections.


Subject(s)
Antifungal Agents , Aspergillus fumigatus , Benzaldehydes , Biofilms , Fusarium , Microbial Sensitivity Tests , Polyphenols , Tannins , Benzaldehydes/pharmacology , Fusarium/drug effects , Tannins/pharmacology , Antifungal Agents/pharmacology , Biofilms/drug effects , Aspergillus fumigatus/drug effects , Animals , Aspergillosis/microbiology , Aspergillosis/drug therapy , Virulence/drug effects , Larva/microbiology , Larva/drug effects , Fusariosis/drug therapy , Fusariosis/microbiology , Spores, Fungal/drug effects , Moths/microbiology , Moths/drug effects
12.
Biomater Adv ; 160: 213863, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38642516

ABSTRACT

To obtain the collaborative antifungal potential of nanocomposites conjugated with graphene oxide (GO), a combination of GO with chitosan (CS/GO) and GO with chitosan (CS) and polyaniline (PANI/CS/GO) was carried out. The synthesized GO-nanocomposites were recognized by several techniques. Vanillin (Van.) and cinnamaldehyde (Cinn.) were loaded on the prepared nanocomposites as antioxidants through a batch adsorption process. In vitro release study of Van. and Cinn. from the nanocomposites was accomplished at pH 7 and 25°C. The antimicrobial activity of GO, CS/GO, and PANI/CS/GO was studied against tomato Fusarium oxysporum (FOL) and Pythium debaryanum (PYD) pathogens. The loaded ternary composite PANI/CS/GO exhibited the best percent of reduction against the two pathogens in vitro studies. The Greenhouse experiment revealed that seedlings' treatment by CS/GO/Van. and PANI/CS/GO/Van significantly lowered both disease index and disease incidence. The loaded CS/GO and PANI/CS/GO nanocomposites had a positive effect on lengthening shoots. Additionally, when CS/GO/Cinn., CS/GO/Van. and PANI/CS/GO/Van. were used, tomato seedlings' photosynthetic pigments dramatically increased as compared to infected control. The results show that these bio-nanocomposites can be an efficient, sustainable, nontoxic, eco-friendly, and residue-free approach for fighting fungal pathogens and improving plant growth.


Subject(s)
Acrolein/analogs & derivatives , Antifungal Agents , Benzaldehydes , Chitosan , Fusarium , Graphite , Nanocomposites , Solanum lycopersicum , Graphite/pharmacology , Graphite/chemistry , Solanum lycopersicum/microbiology , Nanocomposites/chemistry , Antifungal Agents/pharmacology , Antifungal Agents/chemistry , Fusarium/drug effects , Chitosan/pharmacology , Chitosan/chemistry , Benzaldehydes/pharmacology , Benzaldehydes/chemistry , Plant Diseases/microbiology , Plant Diseases/prevention & control , Pythium/drug effects , Aniline Compounds/pharmacology , Aniline Compounds/chemistry , Acrolein/pharmacology , Acrolein/chemistry
13.
Microb Pathog ; 191: 106663, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38679246

ABSTRACT

Quorum sensing (QS) has a central role in biofilm lifestyle and antimicrobial resistance, and disrupting these signaling pathways is a promising strategy to control bacterial pathogenicity and virulence. In this study, the efficacy of three structurally related benzaldehydes (4-hydroxybenzaldehyde, 4-hydroxy-3-methoxybenzaldehyde (vanillin) and 4-hydroxy-3,5-dimethoxybenzaldehyde (syringaldehyde)) in disrupting the las and pqs systems of Pseudomonas aeruginosa was investigated using bioreporter strains and computational simulations. Additionally, these benzaldehydes were combined with tobramycin and ciprofloxacin antibiotics to evaluate their ability to increase antibiotic efficacy in preventing and eradicating P. aeruginosa biofilms. To this end, the total biomass, metabolic activity and culturability of the biofilm cells were determined. In vitro assays results indicated that the aromatic aldehydes have potential to inhibit the las and pqs systems by > 80 %. Molecular docking studies supported these findings, revealing the aldehydes binding in the same pocket as the natural ligands or receptor proteins (LasR, PQSA, PQSE, PQSR). Benzaldehydes were shown to act as virulence factor attenuators, with vanillin achieving a 48 % reduction in pyocyanin production. The benzaldehyde-tobramycin combination led not only to a 60 % reduction in biomass production but also to a 90 % reduction in the metabolic activity of established biofilms. A similar result was observed when benzaldehydes were combined with ciprofloxacin. 4-Hydroxybenzaldehyde demonstrated relevant action in increasing biofilm susceptibility to ciprofloxacin, resulting in a 65 % reduction in biomass. This study discloses, for the first time, that the benzaldehydes studied are potent QS inhibitors and also enhancers of antibiotics antibiofilm activity against P. aeruginosa.


Subject(s)
Anti-Bacterial Agents , Bacterial Proteins , Benzaldehydes , Biofilms , Ciprofloxacin , Molecular Docking Simulation , Pseudomonas aeruginosa , Quorum Sensing , Tobramycin , Biofilms/drug effects , Quorum Sensing/drug effects , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/physiology , Benzaldehydes/pharmacology , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/chemistry , Tobramycin/pharmacology , Ciprofloxacin/pharmacology , Bacterial Proteins/metabolism , Virulence Factors/metabolism , Microbial Sensitivity Tests , Drug Synergism , Pyocyanine/metabolism , Trans-Activators/metabolism , Trans-Activators/antagonists & inhibitors
14.
Exp Parasitol ; 260: 108743, 2024 May.
Article in English | MEDLINE | ID: mdl-38513973

ABSTRACT

Treatment against leishmaniasis presents problems, mainly due to the toxicity of the drugs, high cost, and the emergence of resistant strains. A previous study showed that two vanillin-derived synthetic molecules, 3s [4-(2-hydroxy-3-(4-octyl-1H-1,2,3-triazol-1-yl)propoxy)-3-methoxybenzaldehyde] and 3t [4-(3-(4-decyl-1H-1,2,3-triazol-1-yl)-2-hydroxypropoxy)-3-methoxybenzaldehyde], presented antileishmanial activity against Leishmania infantum, L. amazonensis, and L. braziliensis species. In the present work, 3s and 3t were evaluated to treat L. amazonensis-infected mice. Molecules were used pure or incorporated into Poloxamer 407-based micelles. In addition, amphotericin B (AmpB) and its liposomal formulation, Ambisome®, were used as control. Animals received the treatment and, one and 30 days after, they were euthanized to evaluate immunological, parasitological, and biochemical parameters. Results showed that the micellar compositions (3s/Mic and 3t/Mic) induced significant reductions in the lesion mean diameter and parasite load in the infected tissue and distinct organs, as well as a specific and significant antileishmanial Th1-type immune response, which was based on significantly higher levels of IFN-γ, IL-12, nitrite, and IgG2a isotype antibodies. Drug controls showed also antileishmanial action; although 3s/Mic and 3t/Mic have presented better and more significant parasitological and immunological data, which were based on significantly higher IFN-γ production and lower parasite burden in treated animals. In addition, significantly lower levels of urea, creatinine, alanine transaminase, and aspartate transaminase were found in mice treated with 3s/Mic and 3t/Mic, when compared to the others. In conclusion, results suggest that 3s/Mic and 3t/Mic could be considered as therapeutic candidates to treat against L. amazonensis infection.


Subject(s)
Antiprotozoal Agents , Benzaldehydes , Leishmania mexicana , Mice, Inbred BALB C , Micelles , Animals , Mice , Benzaldehydes/pharmacology , Benzaldehydes/chemistry , Leishmania mexicana/drug effects , Antiprotozoal Agents/pharmacology , Antiprotozoal Agents/therapeutic use , Antiprotozoal Agents/chemistry , Leishmaniasis, Cutaneous/drug therapy , Female , Amphotericin B/pharmacology , Amphotericin B/therapeutic use , Poloxamer/chemistry , Poloxamer/pharmacology , Male , Spleen/parasitology
15.
Microb Pathog ; 190: 106624, 2024 May.
Article in English | MEDLINE | ID: mdl-38492828

ABSTRACT

Pseudomonas aeruginosa is widely associated with biofilm-mediated antibiotic resistant chronic and acute infections which constitute a persistent healthcare challenges. Addressing this threat requires exploration of novel therapeutic strategies involving the combination of natural compounds and conventional antibiotics. Hence, our study has focused on two compounds; cuminaldehyde and ciprofloxacin, which were strategically combined to target the biofilm challenge of P. aeruginosa. The minimum inhibitory concentration (MIC) of cuminaldehyde and ciprofloxacin was found to be 400 µg/mL and 0.4 µg/mL, respectively. Moreover, the fractional inhibitory concentration index (FICI = 0.62) indicated an additive interaction prevailed between cuminaldehyde and ciprofloxacin. Subsequently, sub-MIC doses of cuminaldehyde (25 µg/mL) and ciprofloxacin (0.05 µg/mL) were selected for an array of antibiofilm assays which confirmed their biofilm inhibitory potential without exhibiting any antimicrobial activity. Furthermore, selected doses of the mentioned compounds could manage biofilm on catheter surface by inhibiting and disintegrating existing biofilm. Additionally, the test combination of the mentioned compounds reduced virulence factors secretion, accumulated reactive oxygen species and increased cell-membrane permeability. Thus, the combination of cuminaldehyde and ciprofloxacin demonstrates potential in combating biofilm-associated Pseudomonal threats.


Subject(s)
Anti-Bacterial Agents , Benzaldehydes , Biofilms , Ciprofloxacin , Microbial Sensitivity Tests , Pseudomonas aeruginosa , Reactive Oxygen Species , Biofilms/drug effects , Ciprofloxacin/pharmacology , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/physiology , Anti-Bacterial Agents/pharmacology , Benzaldehydes/pharmacology , Reactive Oxygen Species/metabolism , Virulence Factors , Cymenes/pharmacology , Drug Synergism , Cell Membrane Permeability/drug effects , Humans
16.
Int J Biol Macromol ; 266(Pt 2): 130910, 2024 May.
Article in English | MEDLINE | ID: mdl-38547953

ABSTRACT

In this study, we developed hydrogels using polyvinyl alcohol (PVA), vanillin (V), and a fungus-derived carboxymethyl chitosan (FC) using a freeze-thaw-based method. These hydrogels were strengthened by bonding, including Schiff's base bonding between V and FC and hydrogen bonding between PVA, FC, and V. The physiological properties of these PFCV hydrogels were characterized by FTIR, TGA, compressive mechanical testing, and rheology and water contact angle measurements. FTIR spectra confirmed the effective integration of FC and V into the PVA network. TGA results showed that FC and V enhanced the thermal stability of PFCV hydrogels. Mechanical tests showed increasing the amount of V reduced mechanical properties but did not alter the elastic character of hydrogels. SEM images displayed a well-interconnected porous structure with excellent swelling capacity. In addition, we examined biological properties using cell-based in vitro studies and performed antibacterial assessments to assess suitability for potential wound dressing applications. Prestoblue™ and live/dead cell analysis strongly supported skin fibroblast attachment and viability, DPPH assays indicated substantial antioxidant activity, and PFCV hydrogels showed enhanced antibacterial effects against Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). In summary, incorporating V and FC into PVA hydrogels appears to be attractive for wound dressing applications.


Subject(s)
Anti-Bacterial Agents , Bandages , Benzaldehydes , Chitosan , Chitosan/analogs & derivatives , Hydrogels , Polyvinyl Alcohol , Chitosan/chemistry , Chitosan/pharmacology , Polyvinyl Alcohol/chemistry , Benzaldehydes/chemistry , Benzaldehydes/pharmacology , Hydrogels/chemistry , Hydrogels/pharmacology , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/chemistry , Escherichia coli/drug effects , Freezing , Staphylococcus aureus/drug effects , Antioxidants/pharmacology , Antioxidants/chemistry , Humans , Wound Healing/drug effects , Cell Survival/drug effects , Fibroblasts/drug effects , Rheology
17.
Mol Microbiol ; 121(5): 833-849, 2024 05.
Article in English | MEDLINE | ID: mdl-38308563

ABSTRACT

The nosocomial bacterium Acinetobacter baumannii is protected from antibiotic treatment by acquiring antibiotic resistances and by forming biofilms. Cell attachment, one of the first steps in biofilm formation, is normally induced by environmental metabolites. We hypothesized that vanillic acid (VA), the oxidized form of vanillin and a widely available metabolite, may play a role in A. baumannii cell attachment. We first discovered that A. baumannii actively breaks down VA through the evolutionarily conserved vanABKP genes. These genes are under the control of the repressor VanR, which we show binds directly to VanR binding sites within the vanABKP genes bidirectional promoter. VA in turn counteracts VanR inhibition. We identified a VanR binding site and searched for it throughout the genome, especially in pili encoding promoter genes. We found a VanR binding site in the pilus encoding csu operon promoter and showed that VanR binds specifically to it. As expected, a strain lacking VanR overproduces Csu pili and makes robust biofilms. Our study uncovers the role that VA plays in facilitating the attachment of A. baumannii cells to surfaces, a crucial step in biofilm formation. These findings provide valuable insights into a previously obscure catabolic pathway with significant clinical implications.


Subject(s)
Acinetobacter baumannii , Bacterial Adhesion , Bacterial Proteins , Biofilms , Fimbriae, Bacterial , Gene Expression Regulation, Bacterial , Promoter Regions, Genetic , Vanillic Acid , Acinetobacter baumannii/metabolism , Acinetobacter baumannii/genetics , Acinetobacter baumannii/drug effects , Vanillic Acid/metabolism , Vanillic Acid/pharmacology , Biofilms/growth & development , Bacterial Proteins/metabolism , Bacterial Proteins/genetics , Fimbriae, Bacterial/metabolism , Fimbriae, Bacterial/genetics , Operon , Binding Sites , Benzaldehydes/metabolism , Benzaldehydes/pharmacology
18.
Blood ; 143(21): 2145-2151, 2024 May 23.
Article in English | MEDLINE | ID: mdl-38364110

ABSTRACT

ABSTRACT: Voxelotor is an inhibitor of sickle hemoglobin polymerization that is used to treat sickle cell disease. Although voxelotor has been shown to improve anemia, the clinical benefit on the brain remains to be determined. This study quantified the cerebral hemodynamic effects of voxelotor in children with sickle cell anemia (SCA) using noninvasive diffuse optical spectroscopies. Specifically, frequency-domain near-infrared spectroscopy combined with diffuse correlation spectroscopy were used to noninvasively assess regional oxygen extraction fraction (OEF), cerebral blood volume, and an index of cerebral blood flow (CBFi). Estimates of CBFi were first validated against arterial spin-labeled magnetic resonance imaging (ASL-MRI) in 8 children with SCA aged 8 to 18 years. CBFi was significantly positively correlated with ASL-MRI-measured blood flow (R2 = 0.651; P = .015). Next, a single-center, open-label pilot study was completed in 8 children with SCA aged 4 to 17 years on voxelotor, monitored before treatment initiation and at 4, 8, and 12 weeks (NCT05018728). By 4 weeks, both OEF and CBFi significantly decreased, and these decreases persisted to 12 weeks (both P < .05). Decreases in CBFi were significantly correlated with increases in blood hemoglobin (Hb) concentration (P = .025), whereas the correlation between decreases in OEF and increases in Hb trended toward significance (P = .12). Given that previous work has shown that oxygen extraction and blood flow are elevated in pediatric SCA compared with controls, these results suggest that voxelotor may reduce cerebral hemodynamic impairments. This trial was registered at www.ClinicalTrials.gov as #NCT05018728.


Subject(s)
Anemia, Sickle Cell , Cerebrovascular Circulation , Oxygen , Humans , Anemia, Sickle Cell/blood , Child , Adolescent , Male , Female , Oxygen/blood , Oxygen/metabolism , Child, Preschool , Magnetic Resonance Imaging/methods , Pyrazines/therapeutic use , Pyrazines/administration & dosage , Pilot Projects , Benzaldehydes/therapeutic use , Benzaldehydes/pharmacology , Benzaldehydes/administration & dosage , Spectroscopy, Near-Infrared/methods , Pyrazoles
19.
Plant Physiol Biochem ; 207: 108427, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38367389

ABSTRACT

Fluorescent materials and technologies have become widely used in scientific research, and due to the ability to convert light wavelengths, their application to photosynthetic organisms can affect their development by altering light quality. However, the impacts of fluorescent materials on aquatic plants and their environmental risks remain unclear. To assess the effects of luminescent materials on floating aquatic macrophytes and their rhizosphere microorganisms, 4-(di-p-tolylamino)benzaldehyde-A (DTB-A) and 4-(di-p-tolylamino)benzaldehyde-M (DTB-M) (emitting blue-green and orange-red light, respectively) were added individually and jointly to Spirodela polyrhiza cultures and set at different concentrations (1, 10, and 100 µM). Both DTB-A and DTB-M exhibited phytotoxicity, which increased with concentration under separate treatment. Moreover, the combined group exhibited obvious stress relief at 10 µM compared to the individually treated group. Fluorescence imaging showed that DTB-A and DTB-M were able to enter the cell matrix and organelles of plant leaves and roots. Peroxidation induced cellular damage, contributing to a decrease in superoxide dismutase (SOD) and peroxidase (POD) activities and malondialdehyde (MDA) accumulation. Decomposition of organelle structures, starch accumulation in chloroplasts, and plasmolysis were observed under the ultrastructure, disrupting photosynthetic pigment content and photosynthesis. DTB-A and DTB-M exposure resulted in growth inhibition, dry weight loss, and leaf yellowing in S. polyrhiza. A total of 3519 Operational Taxonomic Units (OTUs) were identified in the rhizosphere microbiome. The microbial communities were dominated by Alphaproteobacteria, Oxyphotobacteria, and Gammaproteobacteria, with the abundance and diversity varied significantly among treatment groups according to Shannon, Simpson, and Chao1 indices. This study revealed the stress defense response of S. polyrhiza to DTB-A and DTB-M exposures, which provides a broader perspective for the bioremediation of pollutants using aquatic plants and supports the further development of fluorescent materials for applications.


Subject(s)
Araceae , Benzaldehydes , Benzaldehydes/pharmacology , Photosynthesis , Antioxidants/metabolism , Chloroplasts/metabolism , Light , Plants/metabolism , Araceae/physiology
20.
Folia Neuropathol ; 62(1): 76-82, 2024.
Article in English | MEDLINE | ID: mdl-38174675

ABSTRACT

This study investigated the protective effect of vanillin against Parkinson's disease (PD). 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP; 30 mg/kg) was administered s.c. for 6 consecutive days to induce PD and mice were treated with vanillin (100 and 200 mg/kg, p.o.) for 15 days. Cognitive, motor and non-motor functions were assessed to evaluate the effect of vanillin in PD mice. Levels of dopamine and glutamate and activity of monoamine oxidaseB (MAO-B) were estimated in vanillin-treated PD mice. The effect of vanillin on the level of lipid peroxidation and superoxide dismutase in brain tissue of PD mice was estimated. Data of the study revealed that vanillin reversed the altered cognitive, motor and non-motor function in PD mice. Activity of MAO-B and neurochemical level were attenuated with vanillin in PD mice. Inflammatory cytokines, nuclear factor kappa B (NF-kB) and Toll-like receptor 4 (TLR-4) levels were lower in the vanillin-treated group compared to the PD group of mice. Data of the study suggest that vanillin protects against neuronal injury and recovers the altered behaviour in PD mice by regulating neurochemical balance and the TLR-4/NF-kB pathway.


Subject(s)
Benzaldehydes , Oxidative Stress , Toll-Like Receptor 4 , Animals , Toll-Like Receptor 4/metabolism , Toll-Like Receptor 4/drug effects , Benzaldehydes/pharmacology , Oxidative Stress/drug effects , Mice , Male , Inflammation/metabolism , 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/pharmacology , Brain/drug effects , Brain/metabolism , Parkinson Disease/metabolism , Parkinson Disease/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...